Balancing between immunosuppressant and infections in lung Transplantation

Gerard Meachery
Freeman Hospital, Newcastle, United Kingdom

Educational Aims

1. Understand the indications for lung transplantation in end stage respiratory disease,
2. Outlining and evaluating key prognostic factors that inform MDT clinical decision making, and specifically potential infection risks in highly immunosuppressed lung transplant recipients.
3. Understanding the important role of the clinical transplant microbiologist.
4. Knowledge application through case-based examples.
5. The importance of monitoring infection risks in patients on a lung transplant waiting list.
6. Key factors in managing the post-lung transplant patient in an acute setting.